Thousands of Children received the vaccine during clinical testing, including children in Kenya.
National Authorities have approved use of the malaria vaccine in the phased introduction.
The introduction of the malaria vaccine will be evaluated
During the introduction of the malaria vaccine, evaluation teams will be visiting communities and working with your chiefs and community health workers to document lessons learned on how best to scale up the vaccine at a larger population
The evaluation teams will be specifically looking at the introduction of the vaccine in order to:
Determine how best to deliver the required four doses of the vaccine in routine settings;
Assess the vaccine’s full potential role in reducing childhood deaths; and
Continue to monitor for any unwanted side effects.
For a start, the vaccine will be given to children in some areas
The malaria vaccine is being given in some areas with moderate to high malaria levels.
The vaccine is being given to eligible children in some areas in Homabay, Kisumu, Migori, Siaya, Busia, Bungoma, Vihiga, and Kakamega counties.
Within the eight counties, some sub-counties will have the opportunity to introduce the vaccine into their immunization schedules, while others are expected to introduce the vaccine later.
Assignment of sub-counties selection, which introduce the vaccine earlier was done through a random selection process in consultation with the respective county health managers.